Novartis AG is 18.0x more valuable than GENMAB A/S by market capitalization ($292.08 B vs $16.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GMAB | NVS |
|---|---|---|
| Market cap | $16.27 B | $292.08 B |
| US-listed rank | #704 | #47 |
| SEC filings | 540 | 947 |
Novartis AG is 18.0x more valuable than GENMAB A/S by market capitalization ($292.08 B vs $16.27 B).
Full pages: GENMAB A/S and Novartis AG, or browse the full rankings.